Prevalence of Sleep Disordered Breathing in a Lung Cancer Screening Cohort
Not Applicable
Completed
- Conditions
- Sleep Apnea Hypopnea SyndromeLung CancerCOPDEmphysema
- Registration Number
- NCT02687997
- Lead Sponsor
- Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
- Brief Summary
Prospective study of sleep disordered breathing in a lung cancer screening cohort.
- Detailed Description
The proposed study is a prospective single arm study evaluating the prevalence of sleep disordered breathing in a cohort of lung cancer screening patients.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 282
Inclusion Criteria
- Age 55-75.
- > 30 pack years tobacco exposure.
- Enrolled in lung cancer screening program.
Exclusion Criteria
- Inability or unwillingness to undergo a home sleep study.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Prevalence of sleep apnea 1 year
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways link sleep apnea hypopnea syndrome to lung cancer progression in high-risk populations?
How does polysomnography compare to home sleep apnea testing in lung cancer screening cohorts with COPD comorbidities?
Which inflammatory biomarkers correlate with sleep disordered breathing severity in emphysema and lung cancer patients?
What adverse events are reported in lung cancer screening protocols when sleep apnea remains undiagnosed?
How does integrating sleep apnea screening with low-dose CT improve early detection in smokers with emphysema?
Trial Locations
- Locations (1)
Fundacion Jimenez Diaz
🇪🇸Madrid, Spain
Fundacion Jimenez Diaz🇪🇸Madrid, Spain